PROTEOMICS SHARED RESOURCE
PROTEOMICS SHARED RESOURCE
批准号:
8340104
负责人:
BRIAN J DRUKER
金额:
$6.13万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-20 至 2016-06-30
关键词:
AcetylationApplications GrantsBindingBiologicalCancer Center Support GrantCancer EtiologyCancer PatientCellsCerebrospinal FluidComplexDataDiseaseDissociationEarly DiagnosisElectron TransportFundingHealth SciencesIndividualInformaticsInstitutesInstructionLabelLiquid substanceMalignant NeoplasmsMass Spectrum AnalysisModificationOregonPatientsPhosphorylationPost-Translational Protein ProcessingProductivityProteinsProteomicsProteomics Shared ResourceRelative (related person)ResearchResearch PersonnelSalivaSamplingSerumSpeedStable Isotope LabelingSubcellular FractionsTechniquesTechnologyTissuesUniversitiesUrineWagesWorkWritinganticancer researcheffective therapyimprovedmass spectrometermembertool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Proteomics Shared Resource provides modern tools of mass spectrometry to Knight Cancer Institute members so that they may determine the identity, abundance, and modifications occurring in proteins, the building blocks of the cell. These analyses are crucial to understanding the cause of cancer and devising improved treatments for the disease, since changes in proteins occur in all forms of cancer. Support will be
used to partially fund salaries of five staff and four state-of-the-art mass spectrometers to assist Knight investigators studying cancer-causing changes in proteins, including phosphorylation, acetylation, changes in abundance and altered binding to other proteins. A wide array of informatics tools and expertise will also be provided to Knight members to increase their research productivity. The results from the Proteomics
Shared Resource will be used to better treat cancer patients by providing earlier diagnosis of the disease and discovering more effective treatments that are personalized for individual patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia
-
批准号:10460000
-
项目类别:
-
资助金额:$118.15万
-
财政年份:2022
-
负责人:BRIAN J DRUKER
-
依托单位:
Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia
-
批准号:10646375
-
项目类别:
-
资助金额:$114.47万
-
财政年份:2022
-
负责人:BRIAN J DRUKER
-
依托单位:
Knight Scholars Program - Building STEM Interest and Capacity for Cancer Research Careers among Underrepresented and Rural High School Students
-
批准号:9788295
-
项目类别:
-
资助金额:$48.32万
-
财政年份:2018
-
负责人:BRIAN J DRUKER
-
依托单位:
Knight Scholars Program - Building STEM Interest and Capacity for Cancer Research Careers among Underrepresented and Rural High School Students
-
批准号:10003014
-
项目类别:
-
资助金额:$29.96万
-
财政年份:2018
-
负责人:BRIAN J DRUKER
-
依托单位:
Knight Scholars Program - Building STEM Interest and Capacity for Cancer Research Careers among Underrepresented and Rural High School Students
-
批准号:10605266
-
项目类别:
-
资助金额:$32.32万
-
财政年份:2018
-
负责人:BRIAN J DRUKER
-
依托单位:
Knight Scholars Program - Building STEM Interest and Capacity for Cancer Research Careers among Underrepresented and Rural High School Students
-
批准号:10381451
-
项目类别:
-
资助金额:$48.57万
-
财政年份:2018
-
负责人:BRIAN J DRUKER
-
依托单位:
Dissecting Single-cell Response or resistance to novel combination therapy in AML using mass cytometry
-
批准号:10411840
-
项目类别:
-
资助金额:$9.33万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
-
批准号:10238859
-
项目类别:
-
资助金额:$100.48万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Translating Improved Pairing and Timing of Drug Combination Strategies
-
批准号:10684113
-
项目类别:
-
资助金额:$30.41万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Architecture and Trajectory of Acquired Resistance to Therapy in AML
-
批准号:10684101
-
项目类别:
-
资助金额:$130.9万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Translating Improved Pairing and Timing of Drug Combination Strategies
-
批准号:10517762
-
项目类别:
-
资助金额:$36.96万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML
-
批准号:9985229
-
项目类别:
-
资助金额:$124.83万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Proteogenomic Translational Research Center for Clinical Proteomic
-
批准号:9272142
-
项目类别:
-
资助金额:$137.46万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML
-
批准号:10012768
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Architecture and Trajectory of Acquired Resistance to Therapy in AML
-
批准号:10517757
-
项目类别:
-
资助金额:$130.9万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML
-
批准号:10249166
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
-
批准号:9362929
-
项目类别:
-
资助金额:$100.48万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML
-
批准号:9444898
-
项目类别:
-
资助金额:$231.0万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Genetics and Signaling of Drug Resistance and Sensitivity in AML Cell Lines, Xenografts, and Primary Patient Samples
-
批准号:10249168
-
项目类别:
-
资助金额:$34.85万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位:
Genetics and Signaling of Drug Resistance and Sensitivity in AML Cell Lines, Xenografts, and Primary Patient Samples
-
批准号:10038083
-
项目类别:
-
资助金额:$34.85万
-
财政年份:2017
-
负责人:BRIAN J DRUKER
-
依托单位: